Boston Heart Diagnostics
Michael Campbell has held various roles in the field of sales compensation and reimbursement analysis. Michael started their career at Genzyme Genetics in 2007 as a Senior Cash Applications Specialist, where they processed daily payments and denials from insurances, clients, and patients. Michael specialized in identifying and applying complex provider level balance transactions. In 2012, they joined Boston Heart Diagnostics as a Reimbursement Associate and continued their responsibilities in processing payments and denials. In 2017, they were promoted to Senior Sales Compensation & Reimbursement Analyst. In 2019, they joined Mimecast as a Sales Compensation Analyst. The end dates for their roles at Boston Heart Diagnostics and Mimecast are not specified.
Michael Campbell attended Stonehill College from 2002 to 2006, where they earned a Bachelor's degree in English.
This person is not in any teams
Boston Heart Diagnostics
Boston Heart Lab is a healthcare company that provides cardiovascular disease (CVD) management. Through there combination of proprietary lipid testing capability, sophisticated tools, advanced therapy guidelines, and patient support services, they are providing physicians, patients, and pharmaceutical companies with viable disease management.Unlike other lipid testing companies that are focused on the primary screening market for CVD, their proprietary testing technology allows for the ongoing monitoring of a patient's disease and precise determination of the most appropriate pharmaceutical alternatives. They can provide unique, personalized treatment options to patients with dyslipidemia to determine the efficacy of lipid adjusting drugs in most cases within the first 6 weeks of treatment. Competing methods usually need 6 months.